Clinical Trial

Soft Tissue Radiation Injury; Patient Reported Evaluation in a Single Centre Cohort Study (STRIPE)

Study acronym: karolinskaUH
Recruiting
View on ClinicalTrials.gov →
Summary
Radiotherapy cures many cancers but can cause late radiation-induced tissue injury (LRTI), leading to long-term symptoms from the bladder and bowel and reduced health-related quality of life (HRQoL). Hyperbaric oxygen therapy (HBOT) is an established treatment that reduces chronic inflammation and promotes tissue repair. Randomized studies have demonstrated improvements in symptoms and quality of life, but only a small proportion of affected patients receive HBOT. This study aims to longitudinally describe a cohort of patients with LRTI treated with HBOT at Karolinska University Hospital and to analyze associations between treatment, timing, and patient characteristics. The goal is to improve understanding of which patients benefit most from HBOT and when treatment should be initiated.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-21.
Trial Details
NCT Number NCT07611864
Lead Sponsor Karolinska University Hospital
Collaborators: Karolinska Institutet
Conditions Cystitis, Radio Induced, Soft Tissue Radionecrosis (STRN), Radiation Proctitis
Enrollment 1,000 participants
Start Date 2026-05-05
Primary Completion 2030-12-31 (estimated)
Study Completion 2040-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-03